Atlas Trials

Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction

Clinical trial NCT03948685 · UNKNOWN

Trial details

NCT number
NCT03948685
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure With Preserved Ejection Fraction
Start date
2019-05-01
Primary completion
2020-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.